Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2025)

Vivos Therapeutics' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.69 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.69 for Q4 2025, down 30.02% from a year ago — trailing twelve months through Dec 2025 was 0.69 (down 30.02% YoY), and the annual figure for FY2025 was 0.86, down 25.34%.
  • Asset Utilization Ratio for Q4 2025 was 0.69 at Vivos Therapeutics, up from 0.67 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.31 in Q4 2023 to a low of 0.36 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.85 (2024), against an average of 0.83.
  • The sharpest move saw Asset Utilization Ratio surged 120.75% in 2022, then crashed 30.02% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.45 in 2021, then surged by 120.75% to 1.0 in 2022, then surged by 31.44% to 1.31 in 2023, then dropped by 25.16% to 0.98 in 2024, then crashed by 30.02% to 0.69 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.69, 0.67, and 0.77 for Q4 2025, Q3 2025, and Q2 2025 respectively.